ClinicalTrials.Veeva

Menu
O

Office of Dr. Alma M. Cruz | Carolina, PR

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Ixekizumab
LY3009104
Mirikizumab
Baricitinib
Tirzepatide
LY3074828
LY3375880
Secukinumab
LY2439821

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 9 total trials

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

The main purpose of this study is to assess the effectiveness of adding tirzepatide to ixekizumab therapy in standard clinical practice in participan...

Enrolling
Psoriasis
Overweight or Obesity
Drug: Tirzepatide

The main purpose of this study is to demonstrate that when participants with moderate to severe plaque psoriasis and obesity or overweight in the pre...

Active, not recruiting
Psoriasis
Obesity
Drug: Tirzepatide
Drug: Ixekizumab

Trial sponsors

Lilly logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems